BioMotiv has established strategic industry partnerships to support technology development and its portfolio companies.
Our partnership with Takeda Pharmaceutical Company leverages the strengths of both organizations to identify and develop pioneering medical innovations in the therapeutic areas of immunology & inflammation and oncology.
Our partnership with Biogen leverages the strengths of both organizations to identify and develop pioneering medical innovations in the therapeutic areas of neurology and ophthalmology.
Our partnership with Arix Bioscience, a global healthcare and life science company supporting medical innovation, enables wide ranging support for innovative university-sourced discoveries, accelerating them into novel medicines.
Our partnership with Charles River Laboratories leverages the strengths of both organizations to advance discoveries sourced from academic research and non-governmental organizations into novel medicines. Charles River Laboratories is the preferred partner for preclinical drug development programs of BioMotiv and its companies.